7-Azaindenoisoquinolines as Anticancer Agents

Back to all technologies
Download as PDF
65926
Topoisomerase 1 (TOP1) is an important protein found in the cell; it is used to unwind and reduce torsional stress on DNA during replication. TOP1 inhibitors are a useful chemotherapy agent because cells that are constantly dividing, such as cancer cells, are much more susceptible to attack; cell death will occur when topoisomerase 1 is inhibited. TOP1 inhibitors make up a large portion of the chemotherapy market because they can be used to target a wide variety of proliferating tumors. The characteristic of uninhibited division is a common feature in cancer that can be targeted without needing a specific marker for each cancer cell type. As more information becomes readily available, it is becoming apparent that within tumors there is a heterogeneous population of cells populating the primary tumor and the secondary tumors.

Researchers at Purdue University have developed a series of 7-azaindenoisoquinoline derivatives that act to inhibit topoisomerase and subsequently induce cell death. This new class of topoisomerase inhibitors has the potential to possess enhanced chemical stability over traditional inhibitors, while increasing inhibitor effectiveness.

Advantages:
-Azaindenoisoquinolines have enhanced chemical stability and effectiveness over other TOP1 inhibitors
-TOP1 is a proven target for cancer therapy

Potential Applications:
-Medical/Healthcare
-Pharmaceuticals
-Cancer Treatment
Mar 6, 2014
CIP-Patent
United States
9,034,870
May 19, 2015

Jul 13, 2012
Utility Patent
United States
8,686,146
Apr 1, 2014

Sep 23, 2014
Provisional-Patent
United States
(None)
(None)

(None)
Provisional-Patent
United States
(None)
(None)
Purdue Office of Technology Commercialization
1801 Newman Road
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486
Email: otcip@prf.org